在基于结构的药物设计中,细节很重要
Bernd Kuhn1, Jens-Uwe Peters2, Markus G Rudolph3
1Roche Pharma Research and Early Development, Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland. bernd.kuhn@roche.com.
Chimia
|December 4, 2023
概括
微小的化学变化通过改变连接体构造和蛋白质相互作用,显著影响药物设计. 数据挖掘结构数据库揭示了对优化候选药物的微妙影响至关重要.
科学领域:
- 药用化学 医学化学
- 结构生物学 结构生物学
- 计算化学计算化学
背景情况:
- 基于结构的药物设计 (SBDD) 需要优化向蛋白相互作用,并最大限度地减少连接体菌株.
- 微妙的化学修饰可以大大改变连接体的首选形状和结合偏好.
研究的目的:
- 突出SBDD中小结构细节的关键重要性.
- 展示晶体结构数据库数据挖掘的实用性,以了解分子识别和指导药物设计.
主要方法:
- 罗氏针对化酶10的项目分析.
- 剑桥结构数据库 (CSD) 的数据挖掘,以确定首选的分子内键模式.
- 使用蛋白质数据库 (PDB) 来推导蛋白质-配体相互作用的倾向.
主要成果:
- 微小的结构变化可以导致连接体行为的显著变化.
- 央行分析发现了分子内键的关键结构动机.
- PDB分析提供了对蛋白质-配体相互作用偏好的见解.
结论:
- 关注微妙的结构细节对于成功的SBDD至关重要.
- 晶体结构数据库是理解分子识别和开发分子设计工具的宝贵资源.
相关概念视频
Structure-Activity Relationships and Drug Design
729
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
729
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Drug-Receptor Bonds
2.9K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.9K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Ligand Binding Sites
7.7K
7.7K


